Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Allergan Plc (AGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 58,789,612
  • Shares Outstanding, K 339,060
  • Annual Sales, $ 15,941 M
  • Annual Income, $ -4,125,500 K
  • 36-Month Beta 1.13
  • Price/Sales 3.74
  • Price/Cash Flow 4.38
  • Price/Book 0.82

Price Performance

See More
Period Period Low Period High Performance
1-Month
163.36 +6.14%
on 07/02/18
178.76 -3.00%
on 06/20/18
+0.34 (+0.20%)
since 06/19/18
3-Month
143.37 +20.94%
on 05/09/18
178.76 -3.00%
on 06/20/18
+14.80 (+9.33%)
since 04/19/18
52-Week
142.81 +21.41%
on 03/05/18
256.80 -32.48%
on 07/25/17
-73.02 (-29.63%)
since 07/19/17

Most Recent Stories

More News
AGN or TLGT: Which Is the Better Value Stock Right Now?

AGN vs. TLGT: Which Stock Is the Better Value Option?

TLGT : 4.01 (-1.23%)
AGN : 173.39 (-1.40%)
AGN vs. TLGT: Which Stock Should Value Investors Buy Now?

AGN vs. TLGT: Which Stock Is the Better Value Option?

TLGT : 4.01 (-1.23%)
AGN : 173.39 (-1.40%)
International Ophthalmology and Optometry Devices Market Booming With New Growth Opportunities

MarketNewsUpdates.com News Commentary

VRX.TO : 30.80 (-3.33%)
EYC.VN : 0.230 (unch)
EYEG : 0.61 (+12.96%)
EYCCF : 0.1869 (+8.85%)
STAA : 33.90 (+0.44%)
AGN : 173.39 (-1.40%)
VRX : 23.40 (-3.43%)
Allergan and Molecular Partners Announce Two Positive Phase 3 Clinical Trials for Abicipar pegol 8 and 12-week Regimens for the Treatment in Patients with Neovascular Age-Related Macular Degeneration

Allergan plc, (NYSE: AGN), a leading global pharmaceutical company and Molecular Partners (SIX: MOLN), a clinical-stage biopharmaceutical company developing a new class of drugs known as DARPin® therapies,...

AGN : 173.39 (-1.40%)
Ironwood Begins New Phase III Study to Expand Linzess Label

Ironwood (IRWD) commences a phase IIIb study in order to add a couple of new symptoms like bloating and discomfort associated with IBS-C to Linzess' label.

IRWD : 20.06 (+0.80%)
AZN : 37.03 (-0.80%)
AGN : 173.39 (-1.40%)
TARO : 113.76 (-0.52%)
Novartis Looks to Exit Antibacterial, Antiviral Program

Per media sources, Novartis is looking to exit its antibacterial and antiviral research program, and cut its headcount.

AZN : 37.03 (-0.80%)
AGN : 173.39 (-1.40%)
NVS : 80.80 (-0.20%)
PFE : 37.36 (-0.80%)
Pharmaceuticals for Women's Health: Global Markets to 2023 - ResearchAndMarkets.com

The "Pharmaceuticals for Women's Health: Global Markets to 2023" report has been added to ResearchAndMarkets.com's offering. While women's health encompasses several health issues,...

BAYRY : 26.9050 (-0.59%)
NVO : 49.81 (-0.82%)
JNJ : 125.94 (-1.46%)
AGN : 173.39 (-1.40%)
ABBV : 89.95 (-4.71%)
AMGN : 191.76 (-0.54%)
Top Analyst Reports for Union Pacific, 21st Century Fox & BP

Top Analyst Reports for Union Pacific, 21st Century Fox & BP

MDLZ : 42.24 (+0.26%)
FOXA : 46.65 (-0.06%)
UNP : 140.41 (-0.59%)
TOT : 61.53 (-0.76%)
AGN : 173.39 (-1.40%)
BP : 44.44 (+0.43%)
Allergan Expands REFRESH® Portfolio With New REFRESH® REPAIR Lubricant Eye Drops

Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced the launch of a new over-the-counter (OTC) artificial tear formulation, REFRESH® REPAIR Lubricant Eye Drops. The first...

AGN : 173.39 (-1.40%)
SmarTrend Watching for Potential Pullback in Shares of Allergan Plc After 1.13% Gain

Allergan Plc (NYSE:AGN) traded in a range yesterday that spanned from a low of $174.67 to a high of $177.49. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $175.63...

AGN : 173.39 (-1.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade AGN with:

Business Summary

Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan...

See More

Key Turning Points

2nd Resistance Point 177.12
1st Resistance Point 175.25
Last Price 173.39
1st Support Level 171.22
2nd Support Level 169.06

See More

52-Week High 256.80
Fibonacci 61.8% 213.26
Fibonacci 50% 199.80
Fibonacci 38.2% 186.35
Last Price 173.39
52-Week Low 142.81

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar